[go: up one dir, main page]

CN1293039C - Preparation of [(S)-(-)-alpha-methylamino phenylketone]2.(2R,3R)-tartaric acid derivative - Google Patents

Preparation of [(S)-(-)-alpha-methylamino phenylketone]2.(2R,3R)-tartaric acid derivative Download PDF

Info

Publication number
CN1293039C
CN1293039C CN 200410024865 CN200410024865A CN1293039C CN 1293039 C CN1293039 C CN 1293039C CN 200410024865 CN200410024865 CN 200410024865 CN 200410024865 A CN200410024865 A CN 200410024865A CN 1293039 C CN1293039 C CN 1293039C
Authority
CN
China
Prior art keywords
tartaric acid
methylamino
methylaminopropiophenone
methylamino propiophenone
propiophenone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN 200410024865
Other languages
Chinese (zh)
Other versions
CN1583714A (en
Inventor
黄成军
周后元
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZHEJIANG APELOA KANGYU PHARMACEUTICAL CO Ltd
Shanghai Institute of Pharmaceutical Industry
Apeloa Pharmaceutical Co Ltd
Original Assignee
Shanghai Institute of Pharmaceutical Industry
Zhejiang Kangyu Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Pharmaceutical Industry, Zhejiang Kangyu Pharmaceutical Co Ltd filed Critical Shanghai Institute of Pharmaceutical Industry
Priority to CN 200410024865 priority Critical patent/CN1293039C/en
Publication of CN1583714A publication Critical patent/CN1583714A/en
Priority to PCT/CN2005/000744 priority patent/WO2005118524A1/en
Application granted granted Critical
Publication of CN1293039C publication Critical patent/CN1293039C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention discloses a preparation method for [(S)-(-)-alpha-methylamino phenylketone]2. (2R, 3R)-tartaric acid derivatives, which comprises: (+/-)-alpha-methylamino propiophenone, (R)-(+)-alpha-methylamino propiophenone, or (R)-(+)-alpha-methylamino propiophenone containing partial (S)-(-)-alpha-methylamino propiophenone and (2R, 3R)-tartarate derivatives react in solvent to form salt, and a target product is collected from a reaction product with a conventional method. The present invention can obtain the target product by only controlling the proportion and the total amount of mixed solvent. The target product with high split optical yield and optical purity can be directly used for synthesizing (1R, 2S)-(-)-ephedrine. The present invention also discloses a directly heating method for racemizing the (R)-(-)-alpha-methylamino propiophenone with no need of additional acid or alkali.

Description

[(S)-(-)-α-甲胺基苯丙酮]2·(2R,3R)-酒石酸衍生物的制备方法 Preparation method of [(S)-(-)-α-methylaminopropiophenone]2·(2R, 3R)-tartaric acid derivative

技术领域technical field

本发明涉及用于制备(1R,2S)-(-)-麻黄碱的中间体:[(S)-(-)-α-甲胺基苯丙酮]2·(2R,3R)-酒石酸衍生物的制备方法。The present invention relates to an intermediate for the preparation of (1R, 2S)-(-)-ephedrine: [(S)-(-)-α-methylaminopropiophenone] 2 ·(2R, 3R)-tartaric acid derivative method of preparation.

背景技术Background technique

(S)-(-)-α-甲胺基苯丙酮或(S)-(-)-α-甲胺基苯丙酮盐是一种重要的医药中间体,可用于制备(1R,2S)-(-)-麻黄碱。(S)-(-)-α-methylaminopropiophenone or (S)-(-)-α-methylaminopropiophenone salt is an important pharmaceutical intermediate, which can be used to prepare (1R, 2S)- (-)-Ephedrine.

[(S)-(-)-α-甲胺基苯丙酮]2·(2R,3R)-酒石酸衍生物一般是通过拆分化合物(±)-α-甲胺基苯丙酮而制得。[(S)-(-)-α-Methylamino Propiophenone] 2 ·(2R,3R)-Tartaric acid derivatives are generally prepared by splitting the compound (±)-α-Methylamino Propiophenone.

中国专利CN1298867A以(1R,3S)-(+)-樟脑酸为拆分剂,将等摩尔的(±)-α-甲胺基苯丙酮与(1R,3S)-(+)-樟脑酸置于乙醇中,加热溶解,冷却结晶,分离出(R)-(+)-α-甲胺基苯丙酮(1R,3S)-(+)-樟脑酸;然后在另一种溶剂体系中析出所需要的(S)-(-)-α-甲胺基苯丙酮(1R,3S)-(+)-樟脑酸,需要经历加热、冷却过程,制备过程比较复杂。Chinese patent CN1298867A takes (1R, 3S)-(+)-camphoric acid as a resolving agent, and equimolar (±)-alpha-methylaminopropiophenone and (1R, 3S)-(+)-camphoric acid are placed In ethanol, heat to dissolve, cool and crystallize, and separate (R)-(+)-α-methylaminopropiophenone (1R, 3S)-(+)-camphoric acid; The required (S)-(-)-α-methylaminopropiophenone (1R, 3S)-(+)-camphoric acid needs to undergo heating and cooling processes, and the preparation process is relatively complicated.

中国专利CN1267664A和CN1265391A以(1R)-(-)-樟脑磺酸为拆分剂,将(±)-α-甲胺基苯丙酮与(1R)-(-)-樟脑磺酸置于水中,加热溶解,冷却结晶,得(S)-(-)-α-甲胺基苯丙酮(1R)-(-)-樟脑磺酸。Chinese patents CN1267664A and CN1265391A use (1R)-(-)-camphorsulfonic acid as a resolving agent, (±)-α-methylaminopropiophenone and (1R)-(-)-camphorsulfonic acid are placed in water, Heating to dissolve, cooling and crystallization to obtain (S)-(-)-α-methylaminopropiophenone (1R)-(-)-camphorsulfonic acid.

但α-甲胺基苯丙酮与有机酸形成的盐对温度较敏感,在加热的情况下(>50℃)易发生副反应,降低拆分光学收率。However, the salt formed by α-methylaminopropiophenone and organic acid is more sensitive to temperature, and under the condition of heating (>50° C.), side reactions are prone to occur, which reduces the resolution optical yield.

美国专利US2802865于室温下将(±)-α-甲胺基苯丙酮与(1S)-(+)-樟脑磺酸或(2R,3R)-(-)-二苯甲酰基酒石酸形成的盐溶于单一溶剂:醇中,然后降温至0-5℃,有晶体析出,但光学纯度不高,通常需结晶数次。由于该盐的溶解度对温度不太敏感,所以拆分效率不高,而且操作繁杂。U.S. Patent No. 2802865 dissolves the salt formed by (±)-α-methylaminopropiophenone and (1S)-(+)-camphorsulfonic acid or (2R, 3R)-(-)-dibenzoyl tartaric acid at room temperature In a single solvent: alcohol, and then cooled to 0-5 ° C, crystals will be precipitated, but the optical purity is not high, usually need to crystallize several times. Since the solubility of the salt is less sensitive to temperature, the resolution is not efficient and the operation is complicated.

Takamatsu(H.Takamatsu,J.Pharm.Soc.Japan,76,1219(1956))公开了以(2R,3R)-(-)-二苯甲酰基酒石酸为拆分剂,将(±)-α-甲胺基苯丙酮与(2R,3R)-(-)-二苯甲酰基酒石酸置于乙酸乙酯中溶解,放置,析出晶体,再以无水乙醇重结晶,Takamatsu宣称已实现不对称转化。但[(±)-α-甲胺基苯丙酮]2·(2R,3R)-(-)-二苯甲酰基酒石酸难溶于乙酸乙酯,须经无水乙醇重结晶后可得目标产品,实验结果难以重现。Takamatsu (H.Takamatsu, J.Pharm.Soc.Japan, 76,1219 (1956)) discloses (2R, 3R)-(-)-dibenzoyl tartaric acid as a resolving agent, (±)-α -Methylaminopropiophenone and (2R, 3R)-(-)-dibenzoyltartaric acid were dissolved in ethyl acetate, placed, crystals were precipitated, and then recrystallized with absolute ethanol, Takamatsu claimed to have achieved asymmetric transformation . However, [(±)-α-methylaminopropiophenone] 2 ·(2R,3R)-(-)-dibenzoyl tartaric acid is insoluble in ethyl acetate, and the target product can be obtained after recrystallization from absolute ethanol , the experimental results are difficult to reproduce.

对于拆分母液,CN1267664A、CN1265391A以及CN1298867A均向拆分母液中加入一定量的碱,加热使α-甲胺基苯丙酮消旋。由于α-甲胺基苯丙酮不稳定,加热15-31h后,发生了副反应,α-甲胺基苯丙酮的回收率较低。For resolving the mother liquor, CN1267664A, CN1265391A and CN1298867A all add a certain amount of alkali to the resolving mother liquor, and heat to make α-methylaminopropiophenone racemize. Because α-methylaminopropiophenone is unstable, after heating for 15-31h, a side reaction occurs, and the recovery rate of α-methylaminopropiophenone is low.

发明内容Contents of the invention

本发明需要解决的技术问题是公开[(S)-(-)-α-甲胺基苯丙酮]2·(2R,3R)-酒石酸衍生物的制备方法,以克服现有技术存在的上述缺陷。The technical problem to be solved in the present invention is to disclose the preparation method of [(S)-(-)-α-methylaminopropiophenone] 2 (2R, 3R)-tartaric acid derivatives to overcome the above-mentioned defects in the prior art .

本发明的方法包括如下步骤:Method of the present invention comprises the steps:

将甲胺基苯丙酮与(2R,3R)-酒石酸衍生物在成盐溶剂中反应成盐,然后在混合溶剂中使[(S)-(-)-α-甲胺基苯丙酮]2·(2R,3R)-酒石酸衍生物析出,通过控制混合溶剂的比例和总量,选择性地使[(S)-(-)-α-甲胺基苯丙酮]2·(2R,3R)-酒石酸衍生物优先析出,而另一非对映异构体由于其溶解度较大,存于母液中。然后采用常规方法,从反应产物中收集[(S)-(-)-α-甲胺基苯丙酮]2·(2R,3R)-酒石酸衍生物;Methylaminopropiophenone and (2R, 3R)-tartaric acid derivatives are reacted to form a salt in a salt-forming solvent, and then [(S)-(-)-α-methylaminopropiophenone] 2 · (2R, 3R)-tartaric acid derivatives are precipitated, and [(S)-(-)-α-methylaminopropiophenone] 2 (2R, 3R)- The tartaric acid derivative was preferentially precipitated, while the other diastereoisomer was present in the mother liquor due to its greater solubility. Then adopt conventional methods to collect [(S)-(-)-α-methylaminopropiophenone] 2 ·(2R, 3R)-tartaric acid derivatives from the reaction product;

所说的甲胺基苯丙酮包括:(±)-α-甲胺基苯丙酮、(R)-(+)-α-甲胺基苯丙酮或夹杂部分(S)-(-)-α-甲胺基苯丙酮的(R)-(+)-α-甲胺基苯丙酮;Said methylaminopropiophenone includes: (±)-α-methylaminopropiophenone, (R)-(+)-α-methylaminopropiophenone or inclusion part (S)-(-)-α- (R)-(+)-α-methylaminopropiophenone of methylaminopropiophenone;

反应温度为0~40℃,反应时间为2~48小时;所说的甲胺基苯丙酮的结构通式为:Reaction temperature is 0~40 ℃, and the reaction time is 2~48 hours; The structural general formula of said methylaminopropiophenone is:

Figure C20041002486500051
Figure C20041002486500051

所说的(2R,3R)-酒石酸衍生物包括:(2R,3R)-(-)-二对甲基苯甲酰基酒石酸、(2R,3R)-(-)-二对甲基苯甲酰基酒石酸一水合物、(2R,3R)-(-)-二间甲基苯甲酰基酒石酸、(2R,3R)-(-)-二间甲基苯甲酰基酒石酸一水合物、(2R,3R)-(-)-二邻甲基苯甲酰基酒石酸、(2R,3R)-(-)-二邻甲基苯甲酰基酒石酸一水合物、(2R,3R)-(-)-二苯甲酰基酒石酸、(2R,3R)-(-)-二苯甲酰基酒石酸一水合物、(2R,3R)-(-)-二乙酰基酒石酸、(2R,3R)-(-)-二乙酰基酒石酸一水合物。Said (2R, 3R)-tartaric acid derivatives include: (2R, 3R)-(-)-di-p-toluyl tartaric acid, (2R, 3R)-(-)-di-p-toluyl tartaric acid Tartaric acid monohydrate, (2R,3R)-(-)-di-m-toluoyl tartaric acid, (2R,3R)-(-)-di-m-toluoyl tartaric acid monohydrate, (2R,3R )-(-)-di-o-tolyl tartaric acid, (2R,3R)-(-)-di-o-tolyl tartaric acid monohydrate, (2R,3R)-(-)-benzoyl tartaric acid Acyl tartaric acid, (2R,3R)-(-)-dibenzoyl tartaric acid monohydrate, (2R,3R)-(-)-diacetyl tartaric acid, (2R,3R)-(-)-diacetyl tartaric acid Tartaric acid monohydrate.

所述及的成盐溶剂选自醇或含水的醇、酯或醚中的一种或其混合物;The salt-forming solvent mentioned is selected from one or a mixture of alcohols or aqueous alcohols, esters or ethers;

所述及的混合溶剂选自醇与酯的混合物、含水的醇与酯的混合物、醇与醚的混合物或含水的醇与醚的混合物中的一种。The mixed solvent mentioned is selected from one of a mixture of alcohol and ester, a mixture of alcohol and ester containing water, a mixture of alcohol and ether or a mixture of alcohol and ether containing water.

其中:所说的醇为C1-C5的醇,即C1-C5OH,酯为C1-C5的酸与C1-C5的醇组成的酯,即C1-C4COOC1-C5,醚为C1-C5的醇与C1-C5的醇组成的醚(即C1-C5OC1-C5)、四氢呋喃或二氧六环中的一种;Wherein: said alcohol is C1-C5 alcohol, namely C1-C5OH, and ester is an ester composed of C 1 -C 5 acid and C 1 -C 5 alcohol, namely C 1 -C 4 COOC 1 -C 5 , the ether is an ether composed of C 1 -C 5 alcohol and C 1 -C 5 alcohol (that is, C 1 -C 5 OC 1 -C 5 ), tetrahydrofuran or dioxane;

当采用酯或醚与醇或含水的醇的混合物为溶剂时,其体积比为:When the mixture of ester or ether and alcohol or water-containing alcohol is used as solvent, its volume ratio is:

酯或醚∶醇或含水的醇=0.5-8.0∶1.0;Ester or ether: alcohol or water-containing alcohol = 0.5-8.0: 1.0;

混合溶剂的体积与(±)-α-甲胺基苯丙酮的重量比为:The volume of mixed solvent and the weight ratio of (±)-α-methylamino Propiophenone are:

1.0-25.0ml/1.0g;1.0-25.0ml/1.0g;

其反应通式如下:Its general reaction formula is as follows:

Figure C20041002486500061
Figure C20041002486500061

其中R为:对甲基苯甲酰基、邻甲基苯甲酰基、间甲基苯甲酰、苯甲酰基或乙酰基;x为0或1。Wherein R is: p-toluyl, o-toluyl, m-toluyl, benzoyl or acetyl; x is 0 or 1.

进一步,由于拆分母液中尚有一定量的(R)-(+)-α-甲胺基苯丙酮,需将该构型的α-甲胺基苯丙酮消旋,套用于下一批的拆分。Further, since there is still a certain amount of (R)-(+)-α-methylaminopropiophenone in the resolution mother liquor, it is necessary to racemize the α-methylaminopropiophenone of this configuration and apply it to the next batch of resolution point.

本发明的(R)-(+)-α-甲胺基苯丙酮的消旋方法包括如下步骤:The racemization method of (R)-(+)-alpha-methylaminopropiophenone of the present invention comprises the steps:

将拆分母液在40~90℃左右加热0.5~4h,加入盐酸、硫酸或磷酸至体系的pH值为1~3左右,搅拌,分出有机层供回收拆分剂用,水层中加入碱金属或碱土金属的氢氧化物至pH值10~14,以有机溶剂萃取已消旋的α-甲胺基苯丙酮,套用于下一批的拆分。Heat the separation mother liquor at about 40-90°C for 0.5-4 hours, add hydrochloric acid, sulfuric acid or phosphoric acid until the pH of the system is about 1-3, stir, separate the organic layer for recovery of the resolving agent, add alkali to the water layer Metal or alkaline earth metal hydroxide to a pH value of 10-14, extract the racemized α-methylaminopropiophenone with an organic solvent, and apply it to the next batch of resolution.

本发明以2摩尔(±)-α-甲胺基苯丙酮与1摩尔拆分剂成盐,如果以手性樟脑酸或樟脑磺酸为拆分剂,则1摩尔拆分剂只能与1摩尔(±)-α-甲胺基苯丙酮成盐,所以本发明的拆分剂利用率较高。The present invention salts with 2 moles of (±)-alpha-methylaminopropiophenone and 1 mole of resolving agent, if with chiral camphoric acid or camphorsulfonic acid as resolving agent, then 1 mole of resolving agent can only be with 1 Mole (±)-alpha-methylaminopropiophenone is salified, so the utilization rate of the resolving agent of the present invention is higher.

研究发现:拆分结果与加料方式无关,详细情况可参见各实施例。Research finds: splitting result has nothing to do with feeding mode, detailed situation can refer to each embodiment.

本发明不需要加热使成盐过程中生成的固体溶解,以及冷却被加热的溶液使固体重析出,即不需要改变体系的温度,在设定的温度下,本发明只需在投料结束后继续搅拌一段时间或搅拌后放置一段时间,过滤后,即可获得[(S)-(-)-α-甲胺基苯丙酮]2·(2R,3R)-酒石酸衍生物。The present invention does not require heating to dissolve the solids generated during the salt-forming process, and cools the heated solution to re-precipitate the solids, that is, there is no need to change the temperature of the system. At the set temperature, the present invention only needs to continue after feeding. After stirring for a period of time or standing for a period of time after stirring, [(S)-(-)-α-methylaminopropiophenone] 2 ·(2R,3R)-tartaric acid derivative can be obtained after filtration.

本发明另一个特点是:拆分光学收率超过理论量,可达158.7%;非对映异构体纯度(%de)经毛细管电泳法测定为97.2%,光学纯度较高,不需另行精制,表明在拆分的过程中实现了部分不对称转化。这是因为溶解度较小的[(S)-(-)-α-甲胺基苯丙酮]2·(2R,3R)-酒石酸衍生物在溶剂中析出后,打破了体系中的平衡,另一种非对映异构体中的(R)-(+)-α-甲胺基苯丙酮在本拆分条件下发生不对称转化,生成[(S)-(-)-α-甲胺基苯丙酮]2·(2R,3R)-酒石酸衍生物,使拆分光学收率超过理论量,达到158.7%。Another feature of the present invention is: the resolution optical yield exceeds the theoretical amount, which can reach 158.7%; the diastereomer purity (%de) is measured as 97.2% by capillary electrophoresis, and the optical purity is relatively high without further refining , indicating that part of the asymmetric transformation was realized during the splitting process. This is because [(S)-(-)-α-methylaminopropiophenone] 2 ·(2R, 3R)-tartaric acid derivatives with low solubility broke the balance in the system after being precipitated in the solvent, and another (R)-(+)-α-methylaminopropiophenone in the two diastereomers undergoes asymmetric transformation under the resolution conditions to generate [(S)-(-)-α-methylaminopropiophenone Propiophenone] 2 ·(2R,3R)-tartaric acid derivatives, the resolution optical yield exceeds the theoretical amount, reaching 158.7%.

既然在拆分的过程中可实现不对称转化,(R)-(+)-α-甲胺基苯丙酮或夹杂部分(S)-(-)-α-甲胺基苯丙酮的(R)-(+)-α-甲胺基苯丙酮与(2R,3R)-酒石酸衍生物在溶剂中成盐后,在适当的条件下应可形成[(S)-(-)-α-甲胺基苯丙酮]2·(2R,3R)-酒石酸衍生物,该盐的溶解度较小,可自反应液中析出,本发明称之为不对称转化法。本发明将(R)-(+)-α-甲胺基苯丙酮或夹杂部分(S)-(-)-α-甲胺基苯丙酮的(R)-(+)-α-甲胺基苯丙酮与(2R,3R)-酒石酸衍生物在溶剂中成盐,通过控制混合溶剂的比例和总量,使因发生不对称转化而生成的[(S)-(-)-α-甲胺基苯丙酮]2·(2R,3R)-酒石酸衍生物选择性地析出,部分未转化的[(R)-(+)-α-甲胺基苯丙酮]2·(2R,3R)-酒石酸衍生物的溶解度较大,溶于母液中。本发明在转化过程中也不需要改变体系的温度,只需在投料结束后,继续搅拌一段时间或搅拌后放置一段时间。过滤后,即可获得[(S)-(-)-α-甲胺基苯丙酮]2·(2R,3R)-酒石酸衍生物,从该盐可制备(S)-(-)-α-甲胺基苯丙酮。Since asymmetric transformation can be achieved during the resolution process, (R)-(+)-α-methylaminopropiophenone or (R) After -(+)-α-methylaminopropiophenone and (2R,3R)-tartaric acid derivatives are salted in a solvent, [(S)-(-)-α-methylamine should be formed under appropriate conditions Propiophenone] 2 · (2R, 3R) - tartaric acid derivatives, the solubility of the salt is small, can be precipitated from the reaction solution, the present invention is called asymmetric conversion method. In the present invention, (R)-(+)-α-methylaminopropiophenone or the (R)-(+)-α-methylaminopropiophenone containing part (S)-(-)-α-methylaminopropiophenone Propiophenone and (2R, 3R)-tartaric acid derivatives form a salt in a solvent, and the [(S)-(-)-α-methylamine generated due to the asymmetric transformation occurs by controlling the ratio and the total amount of the mixed solvent [(R)-(+)-α-methylaminopropiophenone] 2 ·(2R,3R)-tartaric acid derivatives are selectively precipitated, and some unconverted [(R)-(+)-α-methylaminopropiophenone] 2 ·(2R,3R)-tartaric acid Derivatives have high solubility and can be dissolved in mother liquor. In the present invention, there is no need to change the temperature of the system during the conversion process, and it only needs to continue stirring for a period of time or leave it for a period of time after stirring. After filtration, [(S)-(-)-α-methylaminopropiophenone] 2 ·(2R,3R)-tartaric acid derivative can be obtained, from which (S)-(-)-α- Methylaminopropiophenone.

本发明短时间加热拆分母液,便可实现α-甲胺基苯丙酮的消旋,由于加热时间短,减少了α-甲胺基苯丙酮的破坏。此外,由于α-甲胺基苯丙酮仍以盐的形式存在,比游离碱的形式稳定,α-甲胺基苯丙酮的回收率有所提高;另外,由于不需加入酸或碱,减少了物料消耗;同时,在该条件下,拆分剂水解很慢,损失较少。The invention can realize the racemization of α-methylaminopropiophenone by heating and splitting the mother liquor in a short time, and the destruction of α-methylaminopropiophenone is reduced due to the short heating time. In addition, because α-methylaminopropiophenone still exists in the form of salt, it is more stable than the form of free base, and the recovery rate of α-methylaminopropiophenone is improved; in addition, because no need to add acid or alkali, reduce Material consumption; at the same time, under this condition, the hydrolysis of the resolving agent is very slow and the loss is small.

具体实施方式Detailed ways

                         实施例1Example 1

(±)-α-甲胺基苯丙酮的拆分方法1Resolution method of (±)-α-methylaminopropiophenone 1

将24.2g(±)-α-甲胺基苯丙酮溶于80ml甲醇,搅拌下缓慢滴加由27.2g(2R,3R)-(-)-二苯甲酰基酒石酸和80ml甲醇组成的混合溶液,滴毕缓慢加入400ml的乙酸乙酯,放置16h,析出大量固体。过滤,以少许2∶5的甲醇与乙酸乙酯的混合溶剂洗涤,烘干,得40.3g[(S)-(-)-α-甲胺基苯丙酮]2·(2R,3R)-(-)-二苯甲酰基酒石酸盐,mp140-142℃,[α]D-102.0°(c=1.0,CH3OH),拆分光学收率158.7%。Dissolve 24.2g (±)-α-methylaminopropiophenone in 80ml methanol, slowly add dropwise a mixed solution consisting of 27.2g (2R, 3R)-(-)-dibenzoyltartaric acid and 80ml methanol, while stirring, After the dropwise addition, 400ml of ethyl acetate was slowly added and left for 16h, a large amount of solids were precipitated. Filter, wash with a little 2:5 mixed solvent of methanol and ethyl acetate, and dry to obtain 40.3g [(S)-(-)-α-methylaminopropiophenone] 2 ·(2R,3R)-( -)-dibenzoyl tartrate, mp 140-142°C, [α] D -102.0° (c=1.0, CH 3 OH), resolution optical yield 158.7%.

将该盐置于碳酸钠水溶液中,控温小于5℃,以二氯甲烷萃取。蒸出二氯甲烷,可得(S)-(-)-α-甲胺基苯丙酮。The salt was placed in an aqueous solution of sodium carbonate, the temperature was controlled below 5°C, and extracted with dichloromethane. Distill out dichloromethane to obtain (S)-(-)-α-methylaminopropiophenone.

                         实施例2Example 2

(±)-α-甲胺基苯丙酮的拆分方法2Resolution method of (±)-α-methylaminopropiophenone 2

将24.2g(±)-α-甲胺基苯丙酮溶于400ml乙酸乙酯中,搅拌下缓慢滴加由27.2g(2R,3R)-(-)-二苯甲酰基酒石酸和160ml甲醇组成的溶液,滴加过程中便有大量固体析出,滴毕放置16h。过滤,以少许2∶5的甲醇和乙酸乙酯混合溶剂洗涤,烘干,得37.0g[(S)-(-)-α-甲胺基苯丙酮]2(2R,3R)-(-)-二苯甲酰基酒石酸盐,mp140-142℃,[α]D-102°(c=1.0,CH3OH)。拆分光学收率145.9%。Dissolve 24.2g (±)-α-methylaminopropiophenone in 400ml ethyl acetate, slowly add dropwise under stirring solution, a large amount of solids precipitated during the dropping process, and the solution was placed for 16 hours after the dropping. Filter, wash with a little 2:5 mixed solvent of methanol and ethyl acetate, and dry to obtain 37.0g [(S)-(-)-α-methylaminopropiophenone] 2 (2R, 3R)-(-) -Dibenzoyl tartrate, mp 140-142°C, [α] D -102° (c=1.0, CH 3 OH). Resolution optical yield 145.9%.

将该盐置于碳酸钠水溶液中,控温小于5℃,以二氯甲烷萃取。蒸出二氯甲烷,可得(S)-(-)-α-甲胺基苯丙酮。The salt was placed in an aqueous solution of sodium carbonate, the temperature was controlled below 5°C, and extracted with dichloromethane. Distill out dichloromethane to obtain (S)-(-)-α-methylaminopropiophenone.

                         实施例3Example 3

(±)-α-甲胺基苯丙酮的拆分方法3Resolution method of (±)-α-methylaminopropiophenone 3

将27.2g(2R,3R)-(-)-二苯甲酰基酒石酸溶于400ml醋酸乙酯中,搅拌下缓慢滴加由24.2g(±)-α-甲胺基苯丙酮与160ml甲醇组成的溶液,滴加过程中便有大量固体析出,滴毕继续搅拌16h。过滤,以少许2∶5的甲醇和醋酸乙酯混合溶剂洗涤,烘干,得38.1g[(S)-(-)-α-甲胺基苯丙酮]2·(2R,3R)-(-)-二苯甲酰基酒石酸盐,mp140-142℃,[α]D-102°(c=1.0,CH3OH),拆分光学收率150.2%。Dissolve 27.2g (2R, 3R)-(-)-dibenzoyl tartaric acid in 400ml ethyl acetate, slowly add dropwise under stirring solution, a large amount of solids precipitated during the dropwise addition, and continued to stir for 16 hours after the dropwise addition. Filter, wash with a little 2:5 mixed solvent of methanol and ethyl acetate, and dry to obtain 38.1g [(S)-(-)-α-methylaminopropiophenone] 2 ·(2R,3R)-(- )-dibenzoyl tartrate, mp 140-142°C, [α] D -102° (c=1.0, CH 3 OH), resolution optical yield 150.2%.

将该盐置于碳酸钠水溶液中,控温小于5℃,以二氯甲烷萃取。蒸出二氯甲烷,可得(S)-(-)-α-甲胺基苯丙酮。The salt was placed in an aqueous solution of sodium carbonate, the temperature was controlled below 5°C, and extracted with dichloromethane. Distill out dichloromethane to obtain (S)-(-)-α-methylaminopropiophenone.

                           实施例4Example 4

从(R)-(+)-α-甲胺基苯丙酮制备(S)-(-)-α-甲胺基苯丙酮Preparation of (S)-(-)-α-methylaminopropiophenone from (R)-(+)-α-methylaminopropiophenone

将2.4g(R)-(+)-α-甲胺基苯丙酮溶于8ml甲醇中,搅拌下缓慢滴加由2.7g(2R,3R)-(-)-二苯甲酰基酒石酸和20ml乙酸乙酯组成的溶液,滴加过程中便有大量固体析出,滴毕放置24h。过滤,以少许2∶5的甲醇和乙酸乙酯的混合溶剂洗涤,烘干,得2.6g[(S)-(-)-α-甲胺基苯丙酮]2(2R,3R)-(-)-二苯甲酰酒石酸盐,mp140-141℃,[α]D-102°(c=1.0,CH3OH),收率51.6%。Dissolve 2.4g (R)-(+)-α-methylaminopropiophenone in 8ml of methanol, and slowly add dropwise under stirring For the solution composed of ethyl ester, a large amount of solids will be precipitated during the dropwise addition, and the solution should be left for 24 hours after the dropwise addition. Filter, wash with a little 2:5 mixed solvent of methanol and ethyl acetate, and dry to obtain 2.6g [(S)-(-)-α-methylaminopropiophenone] 2 (2R, 3R)-(- )-dibenzoyl tartrate, mp 140-141°C, [α] D -102° (c=1.0, CH 3 OH), yield 51.6%.

                         实施例5Example 5

(R)-(+)-α-甲胺基苯丙酮的消旋Racemization of (R)-(+)-α-methylaminopropiophenone

将实施例1中的拆分母液在50℃左右加热1h左右,加入4N盐酸至体系的pH值为1左右,搅拌,分出有机层供回收拆分剂用。水层中加入30%NaOH水溶液至pH值14左右,以乙酸乙酯萃取已消旋的α-甲胺基苯丙酮,套用于下一批的拆分。Heat the resolution mother liquor in Example 1 at about 50°C for about 1 hour, add 4N hydrochloric acid until the pH of the system is about 1, stir, and separate the organic layer for recovery of the resolution agent. Add 30% NaOH aqueous solution to the aqueous layer until the pH value is about 14, extract the racemic α-methylaminopropiophenone with ethyl acetate, and use it for the next batch of resolution.

                         实施例6~13Example 6-13

采用与实施例1相同的方法,将24.2g(0.148mol)(±)-α-甲胺基苯丙酮溶于80ml甲醇,搅拌下分别缓慢滴加由0.074mol的(2R,3R)-(-)-二对甲基苯甲酰基酒石酸(实施例6)、(2R,3R)-(-)-二对甲基苯甲酰基酒石酸一水合物(实施例7)、(2R,3R)-(-)-二间甲基苯甲酰基酒石酸(实施例8)、(2R,3R)-(-)-二间甲基苯甲酰基酒石酸一水合物(实施例9)、(2R,3R)-(-)-二邻甲基苯甲酰基酒石酸(实施例10)、(2R,3R)-(-)-二邻甲基苯甲酰基酒石酸一水合物(实施例11)、(2R,3R)-(-)-二乙酰基酒石酸(实施例12)、(2R,3R)-(-)-二乙酰基酒石酸一水合物(实施例13)与80ml甲醇组成的混合溶液,滴毕缓慢加入400ml的乙酸乙酯,放置16h,析出大量固体。过滤,以少许2∶5的甲醇与乙酸乙酯的混合溶剂洗涤,烘干,获得[(S)-(-)-α-甲胺基苯丙酮]2·(2R,3R)-(-)-酒石酸衍生物盐,结果如下:Using the same method as in Example 1, 24.2g (0.148mol) (±)-α-methylaminopropiophenone was dissolved in 80ml of methanol, and slowly added dropwise with 0.074mol of (2R, 3R)-(- )-di-p-toluyl tartaric acid (Example 6), (2R, 3R)-(-)-di-p-toluyl tartaric acid monohydrate (Example 7), (2R, 3R)-( -)-Di-m-toluoyl tartaric acid (Example 8), (2R, 3R)-(-)-Di-m-toluoyl tartaric acid monohydrate (Example 9), (2R, 3R)- (-)-Di-o-tolyl tartaric acid (Example 10), (2R, 3R)-(-)-Di-o-toluyl tartaric acid monohydrate (Example 11), (2R, 3R) -(-)-Diacetyl tartaric acid (Example 12), (2R, 3R)-(-)-Diacetyl tartaric acid monohydrate (Example 13) and 80ml methanol mixed solution, dropwise slowly add 400ml The ethyl acetate was left for 16h, and a large amount of solid was precipitated. Filter, wash with a little 2:5 mixed solvent of methanol and ethyl acetate, and dry to obtain [(S)-(-)-α-methylaminopropiophenone] 2 ·(2R,3R)-(-) - Tartaric acid derivative salts, the results are as follows:

                       拆分光学收率%Split optical yield %

实施例6                150.7%Example 6 150.7%

实施例7                148.5%Example 7 148.5%

实施例8                149.6%Example 8 149.6%

实施例9                145.3%Example 9 145.3%

实施例10               151.2%Example 10 151.2%

实施例11               148.3%Example 11 148.3%

实施例12               142.9%Example 12 142.9%

实施例13               140.1%Example 13 140.1%

Claims (5)

1.[(S)-(-)-α-methylamino Propiophenone] 2(2R 3R)-preparation method of tartaric acid derivatives, is characterized in that comprising the steps: with the methylamino Propiophenone with (2R 3R)-tartaric acid derivatives reacts salify in becoming salt solvent, makes in mixed solvent [(S)-(-)-α-methylamino Propiophenone] then 2(2R 3R)-tartaric acid derivatives separates out, adopts conventional method to collect [(S)-(-)-α-methylamino Propiophenone] then 2(2R, 3R)-tartaric acid derivatives;
Said methylamino Propiophenone comprise (±)-α-methylamino Propiophenone, (R)-(+)-α-methylamino Propiophenone or be mingled with the part (S)-(-)-α-methylamino Propiophenone (R)-(+)-α-methylamino Propiophenone in a kind of;
The one-tenth salt solvent of being addressed is selected from a kind of or its mixture in alcohol or aqueous alcohol, ester or the ether;
The mixed solvent of being addressed is selected from alcohol and the mixture of mixture, aqueous alcohol and the ester of ester, pure and the mixture of ether or the mixture of aqueous alcohol and ether; When the mixture that adopts ester or ether and alcohol or aqueous alcohol was solvent, its volume ratio was: ester or ether: pure or aqueous alcohol=0.5-8.0: 1.0;
Wherein: said alcohol is C 1-5OH; Said ester is C 1-4COOC 1-5Said ether is C 1-5OC 1-5, a kind of in tetrahydrofuran (THF) or the dioxane;
The ratio of the volume of mixed solvent and methylamino Propiophenone weight is:
1.0-25.0ml/1.0g。
2. method according to claim 1 is characterized in that: temperature of reaction is 0~40 ℃, and the reaction times is 2~48 hours.
3. method according to claim 1; it is characterized in that: said (2R; 3R)-tartaric acid derivatives comprises (2R; 3R)-(-)-two pair methyl benzoyl tartrate; (2R; 3R)-(-)-two pair methyl benzoyl tartrate monohydrate; (2R; 3R)-(-)-two a methyl benzoyl tartrate; (2R; 3R)-(-)-two a methyl benzoyl tartrate monohydrate; (2R; 3R)-(-)-two o-methyl-benzene formyl radical tartrate; (2R; 3R)-(-)-two o-methyl-benzene formyl radical tartrate monohydrate; (2R; 3R)-(-)-dibenzoyl tartaric acid; (2R; 3R)-(-)-the dibenzoyl tartaric acid monohydrate; (2R; 3R)-(-)-diacetyl tartrate; (2R, 3R)-(-)-diacetyl tartrate monohydrate.
4. according to each described method of claim 1~3, it is characterized in that, also comprise the steps: the fractionation mother liquor is heated 0.5~4h about 40~90 ℃, adding hydrochloric acid, sulfuric acid or phosphoric acid to the pH value of system is about 1~3, stir, tell organic layer for reclaiming resolving agent usefulness, add the oxyhydroxide of basic metal or alkaline-earth metal in the water layer to pH value 10~14, with the α-methylamino Propiophenone of organic solvent extraction racemization.
5. method according to claim 4 is characterized in that: the α of racemization-methylamino Propiophenone cover is used for the fractionation of next batch.
CN 200410024865 2004-06-02 2004-06-02 Preparation of [(S)-(-)-alpha-methylamino phenylketone]2.(2R,3R)-tartaric acid derivative Expired - Lifetime CN1293039C (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN 200410024865 CN1293039C (en) 2004-06-02 2004-06-02 Preparation of [(S)-(-)-alpha-methylamino phenylketone]2.(2R,3R)-tartaric acid derivative
PCT/CN2005/000744 WO2005118524A1 (en) 2004-06-02 2005-05-27 Process for preparing [(s)-(-)alpha-methylamino phenylacetone]2 (2r, 3r)-tartaric acid derivates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200410024865 CN1293039C (en) 2004-06-02 2004-06-02 Preparation of [(S)-(-)-alpha-methylamino phenylketone]2.(2R,3R)-tartaric acid derivative

Publications (2)

Publication Number Publication Date
CN1583714A CN1583714A (en) 2005-02-23
CN1293039C true CN1293039C (en) 2007-01-03

Family

ID=34601012

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200410024865 Expired - Lifetime CN1293039C (en) 2004-06-02 2004-06-02 Preparation of [(S)-(-)-alpha-methylamino phenylketone]2.(2R,3R)-tartaric acid derivative

Country Status (2)

Country Link
CN (1) CN1293039C (en)
WO (1) WO2005118524A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101870660A (en) * 2010-05-10 2010-10-27 青海省青海湖药业有限公司 Preparation method of L-(-)-ephedrine chloride and d-(+)-pseudoephedrine hydrochloride
CN104119240A (en) * 2013-04-23 2014-10-29 中国人民解放军军事医学科学院毒物药物研究所 Preparation method for (S)-(-)-alpha-methylaminopropiophenone
CN104725259B (en) * 2013-12-19 2017-01-18 上海医药工业研究院 Preparation method for levodopa intermediate derivative
CN113024391A (en) * 2021-04-09 2021-06-25 北京旋光普利生物医药科技开发有限公司 Preparation of (S) - (-) -alpha-methylaminopropiophenone

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE538932A (en) * 1954-06-15
US5227526A (en) * 1992-06-16 1993-07-13 Mallinckrodt Specialty Chemicals Company Resolution of 3-dimethylamino-2-methylpropiophenone (3-DAMP)
CN1211349C (en) * 1999-12-06 2005-07-20 赤峰艾克制药科技股份有限公司 Process for preparing alpha-amidophenylketone with optical activity
CN1265391A (en) * 2000-01-31 2000-09-06 李健府 Preparation of levorotary Alpha-methylamino-phenylacetone and repeated usage of separating agent
CN1267664A (en) * 2000-03-14 2000-09-27 李健府 Preparation of levorotary alpha-methylamino phenyl acetone

Also Published As

Publication number Publication date
WO2005118524A1 (en) 2005-12-15
CN1583714A (en) 2005-02-23

Similar Documents

Publication Publication Date Title
CN105189434A (en) Salts of treprostinil
JP2005531633A (en) Preparation of chiral aminonitrile
JP2007516934A (en) Novel process for the preparation of (+)-(S) -clopidogrel bisulfate form-I
WO2019242192A1 (en) Brivaracetam intermediate, preparation method therefor, and preparation method for brivaracetam
KR20120039344A (en) A novel method of making endoxifen
CN1293039C (en) Preparation of [(S)-(-)-alpha-methylamino phenylketone]2.(2R,3R)-tartaric acid derivative
JPH0674243B2 (en) Optically active atenolol salt with high optical purity and process for producing atenolol
KR20010112223A (en) Process for the Resolution of Tramadol
EP2089375B1 (en) A method of purification of (s)-n-methyl-3-(1-naphtyloxy)-3-(2-thienyl) propylamine hydrochloride (duloxetine)
CN1518540A (en) Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-α,α-dimethylphenylacetic acid and its hydrochloride
CN1931855A (en) Compound 2-methylol-3-substituted phenyl propionic acid with optical activity and its resolving process
EP1564209A1 (en) Process for the preparation of 13-cis-retinoic acid
JP2971291B2 (en) Production method of optically active 2-aminobutyric acid
EP2358729A1 (en) Crystallised pentasaccharide, method for obtaining same and use thereof for the preparation of idraparinux
CN1314684C (en) Synthesis method of saijiabin, its racemate and S-configuration, and preparation method of its amorphous powder
CN107827802B (en) Synthesis method of D-proline
JP2010540632A (en) Process for preparing R-gossypol L-phenylalaninol dienamine
CN1181051C (en) New process
Shiraiwa et al. Optical resolution by preferential crystallization of (RS)-2-benzoylamino-2-benzyl-3-hydroxypropanoic acid and its use in synthesizing optically active 2-amino-2-methyl-3-phenylpropanoic acid
CN101880224B (en) Method for splitting 6,8-dichlorocaprylate
CN114989218B (en) Synthetic method of Ruidecy Wei Lin isomer
CN101314574B (en) Synthetic method of acylated enamine
CN103360241B (en) Optical voidness 5-oxo three ring [2,2,1,02,6] preparation method of heptane-3-carboxylic acid
JP2002193933A (en) Production method of optically active piperidine derivative and its acid salt
CN100341850C (en) Salts of demethyl phencynonate isomer and N-para-methyl-phenyl-sulfuryl glutamic acid optical isomer and their preparing method and use

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee
CP01 Change in the name or title of a patent holder

Address after: 200040 Beijing West Road, Shanghai, No. 1320

Patentee after: SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY

Patentee after: ZHEJIANG APELOA KANGYU PHARMACEUTICAL Co.,Ltd.

Address before: 200040 Beijing West Road, Shanghai, No. 1320

Patentee before: Shanghai Institute of pharmaceutical industry

Patentee before: ZHEJIANG KANGYU PHARMACEUTICAL Co.,Ltd.

TR01 Transfer of patent right

Effective date of registration: 20200714

Address after: No.399, Jiangnan Road, Hengdian Town, Dongyang City, Zhejiang Province

Co-patentee after: SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY

Patentee after: APELOA PHARMACEUTICAL Co.,Ltd.

Co-patentee after: ZHEJIANG APELOA KANGYU PHARMACEUTICAL Co.,Ltd.

Address before: 200040 No. 1320 West Beijing Road, Shanghai

Co-patentee before: ZHEJIANG APELOA KANGYU PHARMACEUTICAL Co.,Ltd.

Patentee before: SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY

TR01 Transfer of patent right
DD01 Delivery of document by public notice

Addressee: Xu Wei

Document name: Notification of Passing Examination on Formalities

DD01 Delivery of document by public notice
CX01 Expiry of patent term

Granted publication date: 20070103

CX01 Expiry of patent term